A Structured Strategy for Pharmaceutical Analytical Method Development Based on Quality by Design (Qbd) and Analytical Quality by Design (Aqbd): Core Principles, Methodological Tools, and Regulatory Compliance Considerations
International Journal of Drug Delivery Technology · 19.05.2026 · 16 (30s)
DOI: 10.25258/ijddt.16.30s.87 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.05.2026. Verfasst von Rihana Syed und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Quality by Design (QbD) represents a systematic, science- and risk-based framework for pharmaceutical development that focuses on proactively embedding quality into products rather than relying exclusively on end-product testing. This approach involves the establishment of a Quality Target Product Profile (QTPP), followed by the identification of Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), and Critical Process Parameters (CPPs). A robust design space is subsequently defined using risk assessment methodologies and statistical tools, including Design of Experiments (DoE). Analytical Quality by Design (AQbD) extends these principles to analytical method development by introducing the concept of an Analytical Target Profile (ATP), ensuring that analytical procedures are reliable, robust, and fit for their intended purpose. Regulatory frameworks, particularly the guidelines issued by the International Council for Harmonisation (ICH Q8–Q14), support the implementation of QbD-based strategies and emphasize lifecycle management and continuous improvement. The integration of QbD and AQbD approaches contributes to enhanced product quality, reduced variability, improved cost-effectiveness, and strengthened regulatory compliance. Collectively, these methodologies play a pivotal role in the development of robust analytical methods aligned with contemporary pharmaceutical quality standards
Zitieren
APA
Syed, R., Kumar, R., & Vutla, V. R. (2026). A Structured Strategy for Pharmaceutical Analytical Method Development Based on Quality by Design (Qbd) and Analytical Quality by Design (Aqbd): Core Principles, Methodological Tools, and Regulatory Compliance Considerations. International Journal of Drug Delivery Technology, 16(30s). https://doi.org/10.25258/ijddt.16.30s.87
Vancouver
Syed R, Kumar R, Vutla VR. A Structured Strategy for Pharmaceutical Analytical Method Development Based on Quality by Design (Qbd) and Analytical Quality by Design (Aqbd): Core Principles, Methodological Tools, and Regulatory Compliance Considerations. International Journal of Drug Delivery Technology. 2026;16(30s). doi:10.25258/ijddt.16.30s.87
BibTeX
@article{Syed2026,
author = {Syed, Rihana and Kumar, Rishi and Vutla, Venkata Rao},
title = {A Structured Strategy for Pharmaceutical Analytical Method Development Based on Quality by Design (Qbd) and Analytical Quality by Design (Aqbd): Core Principles, Methodological Tools, and Regulatory Compliance Considerations},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {30s},
doi = {10.25258/ijddt.16.30s.87}
}
EUVIMED